The only thing that matters is the Health Canada application and approval to clinical trials. Once that occurs the molecule and company will become more known and looked at by investors and other biotechs and pharma. With 0 debt and up to date filings if the molecule proves out this is an acquirers dream.
News 
Market Data 
Discover 
